LEVALBUTEROL

LEVALBUTEROL was reported 3733 times

LEVALBUTEROL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COAGULATION FACTOR DEFICIENCY 28 0.1739
1 ACQUIRED FACTOR V DEFICIENCY 19 0.1727
2 COAGULATION FACTOR V LEVEL ABNORMAL 19 0.1545
3 CYSTIC FIBROSIS GASTROINTESTINAL DISEASE 2 0.0800
4 BRAIN NATRIURETIC PEPTIDE DECREASED 4 0.0476
5 FACTOR V LEIDEN MUTATION 15 0.0378
6 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 30 0.0324
7 FIBRINOUS BRONCHITIS 2 0.0263
8 BRONCHOMALACIA 3 0.0227
9 JEJUNOSTOMY 3 0.0165
10 CREATININE RENAL CLEARANCE INCREASED 10 0.0134
11 MULTIPLE DRUG THERAPY 9 0.0119
12 TOXIC OPTIC NEUROPATHY 5 0.0115
13 SEDATION COMPLICATION 29 0.0114
14 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 10 0.0112
15 INFLUENZA B VIRUS TEST POSITIVE 2 0.0110
16 BRONCHOSPASM PARADOXICAL 3 0.0100
17 DEATH OF RELATIVE 4 0.0099
18 INFECTIVE EXACERBATION OF BRONCHIECTASIS 3 0.0098
19 ASPERGILLUS TEST POSITIVE 3 0.0097
20 DEFECT CONDUCTION INTRAVENTRICULAR 3 0.0093
21 TRACHEAL HAEMORRHAGE 3 0.0085
22 TRACHEITIS 6 0.0079
23 CREATININE RENAL CLEARANCE DECREASED 29 0.0072
24 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 36 0.0066
25 STATUS ASTHMATICUS 3 0.0064
26 ADMINISTRATION SITE SWELLING 2 0.0062
27 CATHETER SITE BRUISE 2 0.0060
28 GIARDIASIS 2 0.0059
29 DIET NONCOMPLIANCE 2 0.0054
30 OEDEMATOUS PANCREATITIS 3 0.0053
31 MULTIPLE ALLERGIES 41 0.0052
32 URINARY TRACT INFECTION PSEUDOMONAL 3 0.0050
33 CORNEAL DYSTROPHY 2 0.0048
34 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 4 0.0047
35 INCREASED VISCOSITY OF BRONCHIAL SECRETION 3 0.0047
36 HYPERMAGNESAEMIA 3 0.0046
37 INFUSION SITE DISCOLOURATION 4 0.0045
38 SPUTUM ABNORMAL 3 0.0045
39 INFUSION SITE URTICARIA 3 0.0045
40 FEEDING INTOLERANCE 2 0.0044
41 CATHETER SITE RASH 2 0.0044
42 ARTERIOVENOUS FISTULA 2 0.0041
43 DEPENDENCE ON OXYGEN THERAPY 2 0.0041
44 CYSTIC FIBROSIS 22 0.0040
45 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 3 0.0039
46 DIAPHRAGMATIC DISORDER 3 0.0039
47 ESSENTIAL HYPERTENSION 7 0.0038
48 VENTRICULAR HYPOKINESIA 12 0.0037
49 KIDNEY ENLARGEMENT 4 0.0037
50 RENAL FUNCTION TEST ABNORMAL 17 0.0037
51 HYPERTENSIVE URGENCY 2 0.0036
52 BLOOD MAGNESIUM ABNORMAL 2 0.0036
53 VOCAL CORD DISORDER 7 0.0035
54 IMPAIRED QUALITY OF LIFE 51 0.0035
55 JUGULAR VEIN DISTENSION 2 0.0035
56 TRACHEOSTOMY 5 0.0035
57 ENTEROVIRUS INFECTION 3 0.0035
58 ANAEMIA OF CHRONIC DISEASE 3 0.0033
59 INFUSION SITE PRURITUS 10 0.0032
60 INFUSION SITE HAEMORRHAGE 10 0.0030
61 SPUTUM RETENTION 3 0.0030
62 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
63 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 4 0.0030
64 INFUSION SITE RASH 4 0.0029
65 MAST CELL ACTIVATION SYNDROME 4 0.0028
66 GLASSY EYES 2 0.0028
67 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
68 BRONCHIAL WALL THICKENING 2 0.0028
69 IMMUNISATION REACTION 2 0.0028
70 INFUSION SITE BRUISING 6 0.0028
71 BLOOD CALCIUM DECREASED 30 0.0027
72 PNEUMONIA PSEUDOMONAL 4 0.0026
73 RHINOVIRUS INFECTION 10 0.0026
74 CROUP INFECTIOUS 2 0.0025
75 PNEUMONIA INFLUENZAL 3 0.0025
76 PULMONARY FUNCTION TEST DECREASED 11 0.0025
77 CHRONIC RESPIRATORY FAILURE 3 0.0025
78 CARTILAGE ATROPHY 2 0.0025
79 POST-ACUTE COVID-19 SYNDROME 3 0.0024
80 DYSCHROMATOPSIA 2 0.0024
81 PULMONARY PAIN 7 0.0024
82 NEPHROGENIC ANAEMIA 11 0.0024
83 INFECTED BITE 2 0.0024
84 INFUSION SITE IRRITATION 3 0.0023
85 CRANIOFACIAL FRACTURE 2 0.0023
86 HYPERPHOSPHATAEMIA 5 0.0023
87 CYSTOCELE 2 0.0023
88 HYPERLEUKOCYTOSIS 2 0.0023
89 BLOOD MAGNESIUM INCREASED 2 0.0022
90 CONGENITAL ANOMALY 17 0.0022
91 PNEUMONIA VIRAL 7 0.0022
92 SEASONAL ALLERGY 31 0.0022
93 RESPIRATORY TRACT INFECTION VIRAL 5 0.0021
94 INCORRECT DRUG ADMINISTRATION RATE 9 0.0021
95 ARNOLD-CHIARI MALFORMATION 2 0.0021
96 COR PULMONALE 2 0.0021
97 BRONCHIECTASIS 14 0.0021
98 TORSADE DE POINTES 16 0.0020
99 PRECANCEROUS SKIN LESION 3 0.0020
100 PNEUMONIA FUNGAL 8 0.0020
101 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
102 CONJUNCTIVITIS ALLERGIC 3 0.0020
103 ORTHOSTATIC HYPOTENSION 35 0.0020
104 HYPERPARATHYROIDISM SECONDARY 5 0.0020
105 CENTRAL VENOUS CATHETERISATION 6 0.0020
106 NEURITIS 3 0.0019
107 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
108 CATHETER SITE PAIN 5 0.0019
109 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
110 GASTROINTESTINAL STOMA COMPLICATION 3 0.0019
111 PHARYNGEAL PARAESTHESIA 3 0.0019
112 ASTHMA 213 0.0019
113 INNER EAR DISORDER 2 0.0019
114 CATHETER SITE ERYTHEMA 4 0.0019
115 PSEUDOMONAS INFECTION 16 0.0019
116 MYCOBACTERIUM AVIUM COMPLEX INFECTION 5 0.0019
117 IDIOPATHIC URTICARIA 2 0.0019
118 SPUTUM INCREASED 4 0.0018
119 INFUSION SITE MASS 2 0.0018
120 OXYGEN SATURATION ABNORMAL 5 0.0018
121 INFUSION SITE SWELLING 11 0.0017
122 CEREBRAL VENTRICLE DILATATION 2 0.0017
123 SPLENIC INFARCTION 3 0.0017
124 INFUSION SITE DISCHARGE 3 0.0017
125 MITRAL VALVE DISEASE 3 0.0017
126 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 87 0.0017
127 BRONCHITIS CHRONIC 4 0.0016
128 PARANASAL SINUS DISCOMFORT 6 0.0016
129 PARANASAL SINUS HYPERSECRETION 6 0.0016
130 BRONCHIAL SECRETION RETENTION 2 0.0016
131 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
132 ACUTE RESPIRATORY FAILURE 29 0.0015
133 ANXIETY DISORDER 5 0.0015
134 CARBON DIOXIDE INCREASED 2 0.0015
135 CHEST INJURY 3 0.0014
136 LUNG CONSOLIDATION 4 0.0014
137 FORCED EXPIRATORY VOLUME DECREASED 4 0.0014
138 RESPIRATORY SYMPTOM 4 0.0014
139 INFUSION SITE PAIN 18 0.0014
140 ADENOVIRUS INFECTION 4 0.0014
141 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
142 GENERALISED ANXIETY DISORDER 2 0.0014
143 CATHETERISATION CARDIAC 6 0.0014
144 RHINITIS ALLERGIC 6 0.0013
145 HYPOSMIA 2 0.0013
146 GASTROSTOMY 2 0.0013
147 EYELIDS PRURITUS 4 0.0013
148 SEDATION 33 0.0013
149 RADIUS FRACTURE 3 0.0012
150 AORTIC VALVE DISEASE 2 0.0012
151 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
152 COSTOCHONDRITIS 2 0.0012
153 RESPIRATORY TRACT INFECTION 32 0.0012
154 BREATH SOUNDS ABNORMAL 6 0.0012
155 SUFFOCATION FEELING 3 0.0012
156 GASTROINTESTINAL TUBE INSERTION 3 0.0012
157 LAZINESS 2 0.0012
158 HEPATOSPLENOMEGALY 3 0.0012
159 ACUTE SINUSITIS 2 0.0012
160 SPUTUM DISCOLOURED 11 0.0012
161 BRONCHIOLITIS 4 0.0011
162 CANDIDA INFECTION 19 0.0011
163 STEATORRHOEA 3 0.0011
164 SHOULDER ARTHROPLASTY 3 0.0011
165 IRON DEFICIENCY ANAEMIA 10 0.0011
166 ENDOTRACHEAL INTUBATION 3 0.0011
167 RESPIRATORY TRACT CONGESTION 17 0.0011
168 VENTRICULAR EXTRASYSTOLES 11 0.0011
169 SECRETION DISCHARGE 13 0.0010
170 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
171 PRODUCTIVE COUGH 49 0.0010
172 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
173 METABOLIC ENCEPHALOPATHY 3 0.0010
174 HYPERCAPNIA 3 0.0010
175 REBOUND ACID HYPERSECRETION 3 0.0010
176 DEVICE DEPOSIT ISSUE 2 0.0010
177 UPPER RESPIRATORY TRACT INFECTION 45 0.0010
178 SINUS CONGESTION 13 0.0010
179 FLANK PAIN 9 0.0010
180 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 46 0.0010
181 BRAIN FOG 15 0.0010
182 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
183 EYE CONTUSION 2 0.0009
184 TONGUE DISCOMFORT 4 0.0009
185 ORTHOPNOEA 3 0.0009
186 FOOD POISONING 5 0.0009
187 END STAGE RENAL DISEASE 17 0.0009
188 APHONIA 13 0.0009
189 JAW FRACTURE 2 0.0009
190 BRONCHOSPASM 13 0.0009
191 APPETITE DISORDER 6 0.0009
192 CHRONIC GASTRITIS 2 0.0009
193 BLOOD LOSS ANAEMIA 2 0.0009
194 DISEASE COMPLICATION 4 0.0009
195 EAR DISORDER 4 0.0009
196 HYPOPNOEA 3 0.0009
197 OXYGEN SATURATION DECREASED 48 0.0009
198 LUNG TRANSPLANT 3 0.0008
199 BACTERAEMIA 10 0.0008
200 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
201 ORAL CANDIDIASIS 11 0.0008
202 FACIAL BONES FRACTURE 3 0.0008
203 GASTROINTESTINAL OBSTRUCTION 2 0.0008
204 INFUSION SITE ERYTHEMA 7 0.0008
205 ATELECTASIS 8 0.0008
206 SPONDYLITIS 3 0.0008
207 BRONCHITIS 61 0.0008
208 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
209 ASPIRATION 9 0.0008
210 VITAMIN D DEFICIENCY 8 0.0008
211 SINUSITIS 84 0.0008
212 HAEMATOLOGICAL INFECTION 2 0.0008
213 PHARYNGEAL SWELLING 8 0.0008
214 DERMAL CYST 2 0.0008
215 ARTHROPOD BITE 6 0.0008
216 MUSCLE STRAIN 7 0.0008
217 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
218 DEVICE INFUSION ISSUE 2 0.0008
219 DYSPHONIA 47 0.0008
220 CHRONIC SINUSITIS 3 0.0008
221 SNORING 3 0.0008
222 EAR INFECTION 21 0.0008
223 HAEMOPTYSIS 22 0.0008
224 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
225 INCREASED BRONCHIAL SECRETION 2 0.0008
226 WHEEZING 46 0.0008
227 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
228 OROPHARYNGEAL DISCOMFORT 7 0.0008
229 REHABILITATION THERAPY 3 0.0008
230 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13 0.0008
231 PNEUMONIA BACTERIAL 7 0.0008
232 OBSTRUCTION 3 0.0008
233 ILLNESS 77 0.0007
234 PNEUMONIA 241 0.0007
235 GINGIVITIS 4 0.0007
236 DECREASED ACTIVITY 8 0.0007
237 EAR CONGESTION 2 0.0007
238 CHRONIC KIDNEY DISEASE 56 0.0007
239 PERIPHERAL VENOUS DISEASE 3 0.0007
240 SMALL INTESTINAL OBSTRUCTION 9 0.0007
241 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
242 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
243 ELECTROCARDIOGRAM QT PROLONGED 26 0.0007
244 COGNITIVE DISORDER 33 0.0007
245 HEART VALVE INCOMPETENCE 2 0.0007
246 PNEUMOTHORAX 11 0.0007
247 HYPERTONIC BLADDER 2 0.0007
248 VIRAL INFECTION 23 0.0007
249 TOOTH INJURY 3 0.0007
250 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
251 ESCHERICHIA SEPSIS 2 0.0007
252 DYSPHEMIA 3 0.0007
253 DECREASED INTEREST 4 0.0007
254 CREPITATIONS 2 0.0007
255 INFUSION SITE REACTION 2 0.0007
256 GASTROINTESTINAL INFECTION 6 0.0007
257 ATYPICAL PNEUMONIA 2 0.0007
258 VENTRICULAR TACHYCARDIA 11 0.0007
259 EYE INJURY 2 0.0007
260 DEVICE DELIVERY SYSTEM ISSUE 18 0.0007
261 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
262 CONCUSSION 5 0.0006
263 ROSACEA 3 0.0006
264 HEPATIC ENCEPHALOPATHY 6 0.0006
265 INFUSION SITE EXTRAVASATION 4 0.0006
266 PELVIC FRACTURE 5 0.0006
267 COUGH 180 0.0006
268 PRE-EXISTING CONDITION IMPROVED 4 0.0006
269 PULMONARY HAEMORRHAGE 5 0.0006
270 BLOOD CREATININE DECREASED 2 0.0006
271 GASTROINTESTINAL INFLAMMATION 5 0.0006
272 DYSPNOEA EXERTIONAL 24 0.0006
273 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
274 NASAL DISCOMFORT 5 0.0006
275 THROAT TIGHTNESS 17 0.0006
276 DYSPNOEA 355 0.0006
277 ATRIAL FLUTTER 5 0.0006
278 HEART RATE INCREASED 62 0.0006
279 CUSHINGOID 2 0.0006
280 DERMATITIS CONTACT 7 0.0006
281 POLYP 4 0.0006
282 LEUKOCYTOSIS 11 0.0006
283 HYPERVOLAEMIA 3 0.0006
284 RENAL INJURY 18 0.0006
285 SINUS DISORDER 12 0.0006
286 MUCOUS STOOLS 3 0.0006
287 PULMONARY MASS 9 0.0006
288 THROAT IRRITATION 27 0.0006
289 COVID-19 PNEUMONIA 7 0.0006
290 INSURANCE ISSUE 9 0.0006
291 IMPAIRED GASTRIC EMPTYING 8 0.0006
292 EAR DISCOMFORT 6 0.0006
293 BRONCHOPNEUMONIA 2 0.0006
294 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
295 LEFT VENTRICULAR FAILURE 2 0.0006
296 RESPIRATION ABNORMAL 4 0.0006
297 RESPIRATORY DISTRESS 16 0.0006
298 LYMPHOEDEMA 4 0.0006
299 URINE OUTPUT DECREASED 5 0.0006
300 RIGHT VENTRICULAR FAILURE 4 0.0006
301 BLOOD LACTIC ACID INCREASED 3 0.0006
302 RESPIRATORY DISORDER 17 0.0006
303 ORAL HERPES 11 0.0006
304 GLOSSITIS 2 0.0006
305 FIBRIN D DIMER INCREASED 2 0.0006
306 HAEMORRHAGIC DIATHESIS 2 0.0006
307 COMPRESSION FRACTURE 3 0.0006
308 BALANCE DISORDER 48 0.0006
309 PARAESTHESIA ORAL 8 0.0006
310 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
311 OROPHARYNGEAL PAIN 51 0.0006
312 SENSITIVE SKIN 4 0.0005
313 HEART RATE ABNORMAL 3 0.0005
314 RIB FRACTURE 11 0.0005
315 PRODUCT LEAKAGE 3 0.0005
316 CHEMOTHERAPY 2 0.0005
317 TENDON PAIN 4 0.0005
318 PULMONARY HYPERTENSION 11 0.0005
319 EXERCISE TOLERANCE DECREASED 3 0.0005
320 SEIZURE 60 0.0005
321 FOOD ALLERGY 4 0.0005
322 CHEST DISCOMFORT 53 0.0005
323 PRODUCT TASTE ABNORMAL 7 0.0005
324 TACHYPNOEA 7 0.0005
325 HOSPITALISATION 79 0.0005
326 HYPOVOLAEMIA 3 0.0005
327 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
328 LUNG DISORDER 25 0.0005
329 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36 0.0005
330 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
331 LIGAMENT SPRAIN 5 0.0005
332 ORAL DISCOMFORT 7 0.0005
333 BLADDER DISORDER 5 0.0005
334 OBESITY 8 0.0005
335 CEREBRAL ATROPHY 2 0.0005
336 SYMPTOM RECURRENCE 3 0.0005
337 MOBILITY DECREASED 36 0.0005
338 WRIST FRACTURE 6 0.0005
339 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
340 INJECTION SITE VESICLES 3 0.0005
341 EMPHYSEMA 5 0.0005
342 FUNGAL SKIN INFECTION 2 0.0005
343 DERMATITIS ACNEIFORM 3 0.0005
344 EYELID PTOSIS 5 0.0005
345 INTENTIONAL DOSE OMISSION 14 0.0005
346 SNEEZING 11 0.0005
347 ABNORMAL FAECES 4 0.0005
348 INITIAL INSOMNIA 5 0.0005
349 GENERALISED OEDEMA 6 0.0005
350 BACTERIAL INFECTION 9 0.0005
351 PETECHIAE 5 0.0005
352 PRODUCT ODOUR ABNORMAL 5 0.0005
353 NASAL CONGESTION 28 0.0005
354 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
355 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
356 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
357 FACIAL PARALYSIS 4 0.0005
358 RESPIRATORY FAILURE 34 0.0005
359 SKIN HYPERPIGMENTATION 4 0.0005
360 CARDIAC OPERATION 4 0.0005
361 HYPOAESTHESIA ORAL 7 0.0005
362 CARDIAC FLUTTER 3 0.0005
363 EAR PAIN 9 0.0005
364 HORDEOLUM 2 0.0005
365 PHARYNGITIS STREPTOCOCCAL 5 0.0005
366 THERAPY INTERRUPTED 33 0.0005
367 HERPES SIMPLEX 3 0.0005
368 SKIN SWELLING 4 0.0005
369 CHAPPED LIPS 2 0.0005
370 SKIN LACERATION 5 0.0005
371 PULMONARY THROMBOSIS 5 0.0005
372 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
373 HAEMORRHAGIC ANAEMIA 2 0.0005
374 HYPOXIA 16 0.0005
375 ABDOMINAL ABSCESS 2 0.0005
376 CARDIAC FAILURE ACUTE 3 0.0004
377 SPINAL FRACTURE 9 0.0004
378 POST-TRAUMATIC STRESS DISORDER 3 0.0004
379 ANAL INCONTINENCE 4 0.0004
380 COVID-19 77 0.0004
381 HAEMOGLOBIN INCREASED 2 0.0004
382 EXOSTOSIS 4 0.0004
383 JOINT EFFUSION 3 0.0004
384 NERVE COMPRESSION 4 0.0004
385 DIVERTICULITIS 12 0.0004
386 CONJUNCTIVITIS 8 0.0004
387 NEPHROPATHY 4 0.0004
388 KNEE ARTHROPLASTY 9 0.0004
389 PAPULE 3 0.0004
390 SINUS TACHYCARDIA 6 0.0004
391 RETCHING 9 0.0004
392 DRY EYE 21 0.0004
393 FEELING JITTERY 8 0.0004
394 MACULAR DEGENERATION 5 0.0004
395 PULMONARY FIBROSIS 8 0.0004
396 MUSCULAR WEAKNESS 47 0.0004
397 DIZZINESS POSTURAL 4 0.0004
398 ADRENAL INSUFFICIENCY 5 0.0004
399 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
400 INFECTION 59 0.0004
401 HYPOTHYROIDISM 13 0.0004
402 SPINAL OPERATION 5 0.0004
403 INFLUENZA 45 0.0004
404 CONSTIPATION 88 0.0004
405 INABILITY TO AFFORD MEDICATION 4 0.0004
406 IMMUNODEFICIENCY 6 0.0004
407 PALPITATIONS 47 0.0004
408 HEPATIC ENZYME ABNORMAL 2 0.0004
409 ATRIAL FIBRILLATION 39 0.0004
410 SALIVARY HYPERSECRETION 4 0.0004
411 POOR QUALITY DEVICE USED 4 0.0004
412 ANAPHYLACTIC REACTION 22 0.0004
413 KLEBSIELLA INFECTION 2 0.0004
414 OSTEOPENIA 6 0.0004
415 TASTE DISORDER 8 0.0004
416 STAPHYLOCOCCAL INFECTION 13 0.0004
417 DRY THROAT 4 0.0004
418 ACUTE KIDNEY INJURY 60 0.0004
419 GASTROENTERITIS VIRAL 7 0.0004
420 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
421 URINARY TRACT INFECTION 66 0.0004
422 EYE PRURITUS 13 0.0004
423 LUNG INFECTION 6 0.0004
424 CARDIAC FAILURE CONGESTIVE 31 0.0004
425 EYE DISCHARGE 4 0.0004
426 HYPOTENSION 77 0.0004
427 TRANSFUSION 4 0.0004
428 PRODUCT USE COMPLAINT 6 0.0004
429 INCONTINENCE 4 0.0004
430 THERAPY NON-RESPONDER 17 0.0004
431 EATING DISORDER 8 0.0004
432 BODY HEIGHT DECREASED 4 0.0004
433 FLUID RETENTION 19 0.0004
434 SENSORY LOSS 3 0.0004
435 QUALITY OF LIFE DECREASED 5 0.0004
436 BEHAVIOUR DISORDER 2 0.0004
437 ERYTHEMA OF EYELID 2 0.0004
438 FOOT FRACTURE 7 0.0004
439 RENAL FAILURE 49 0.0004
440 POST PROCEDURAL INFECTION 3 0.0004
441 LIMB INJURY 10 0.0004
442 ASPHYXIA 3 0.0004
443 PRODUCT DOSE OMISSION ISSUE 108 0.0004
444 HYDROCEPHALUS 2 0.0004
445 ESCHERICHIA INFECTION 3 0.0004
446 AUTISM SPECTRUM DISORDER 2 0.0004
447 SPINAL COMPRESSION FRACTURE 3 0.0004
448 ACUTE CORONARY SYNDROME 3 0.0004
449 EPISTAXIS 27 0.0004
450 FUNGAL INFECTION 12 0.0004
451 NERVE INJURY 4 0.0004
452 GAIT INABILITY 12 0.0004
453 SKIN INFECTION 4 0.0004
454 BLINDNESS UNILATERAL 5 0.0004
455 EYE INFECTION 4 0.0004
456 BLOOD PRESSURE ABNORMAL 7 0.0004
457 UPPER LIMB FRACTURE 7 0.0004
458 VITAMIN D DECREASED 3 0.0004
459 SCAR 6 0.0004
460 INTERNAL HAEMORRHAGE 4 0.0003
461 TACHYCARDIA 31 0.0003
462 MUSCULOSKELETAL DISCOMFORT 6 0.0003
463 MIGRAINE 33 0.0003
464 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
465 ELECTROLYTE IMBALANCE 4 0.0003
466 SPINAL OSTEOARTHRITIS 3 0.0003
467 HYPERCHLORHYDRIA 2 0.0003
468 LUNG INFILTRATION 3 0.0003
469 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
470 BLOOD IRON DECREASED 4 0.0003
471 CATARACT OPERATION 2 0.0003
472 FACIAL PAIN 3 0.0003
473 CARDIAC PACEMAKER INSERTION 2 0.0003
474 ABDOMINAL DISTENSION 35 0.0003
475 HYPERLIPIDAEMIA 4 0.0003
476 HERPES ZOSTER 19 0.0003
477 PNEUMONITIS 9 0.0003
478 LIP DRY 3 0.0003
479 IRRITABLE BOWEL SYNDROME 7 0.0003
480 HYPOKALAEMIA 15 0.0003
481 LARYNGEAL OEDEMA 2 0.0003
482 FALL 108 0.0003
483 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
484 HYPERCALCAEMIA 4 0.0003
485 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
486 PHARYNGITIS 4 0.0003
487 CYST 4 0.0003
488 CONTUSION 31 0.0003
489 DRY MOUTH 26 0.0003
490 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
491 TREMOR 53 0.0003
492 CATARACT 19 0.0003
493 CHEST PAIN 59 0.0003
494 MELAENA 7 0.0003
495 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
496 PRODUCT PACKAGING ISSUE 3 0.0003
497 DRUG INTERACTION 50 0.0003
498 EYE INFLAMMATION 3 0.0003
499 SLEEP APNOEA SYNDROME 6 0.0003
500 FOREIGN BODY SENSATION IN EYES 2 0.0003
501 ABSCESS 5 0.0003
502 LOWER LIMB FRACTURE 6 0.0003
503 PLEURAL EFFUSION 19 0.0003
504 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
505 HAEMOGLOBIN ABNORMAL 2 0.0003
506 HYPERCHOLESTEROLAEMIA 3 0.0003
507 CHROMATURIA 7 0.0003
508 RHINORRHOEA 20 0.0003
509 AUTOIMMUNE DISORDER 3 0.0003
510 CHOKING 6 0.0003
511 NODULE 4 0.0003
512 RENAL TUBULAR NECROSIS 3 0.0003
513 KIDNEY INFECTION 6 0.0003
514 NASOPHARYNGITIS 56 0.0003
515 PULMONARY CONGESTION 4 0.0003
516 PERICARDIAL EFFUSION 7 0.0003
517 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
518 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
519 GASTROINTESTINAL DISORDER 27 0.0003
520 LIP SWELLING 10 0.0003
521 LACRIMATION INCREASED 9 0.0003
522 BREAST MASS 2 0.0003
523 SLEEP DISORDER 21 0.0003
524 FACE OEDEMA 5 0.0003
525 COLITIS ISCHAEMIC 2 0.0003
526 EYE IRRITATION 17 0.0003
527 PRODUCT USE IN UNAPPROVED INDICATION 73 0.0003
528 SLUGGISHNESS 3 0.0003
529 MOOD ALTERED 8 0.0003
530 EYE MOVEMENT DISORDER 2 0.0003
531 HAEMATURIA 10 0.0003
532 TEMPERATURE INTOLERANCE 3 0.0003
533 COLITIS 11 0.0003
534 CHILLS 34 0.0003
535 POOR VENOUS ACCESS 3 0.0003
536 LARGE INTESTINE POLYP 2 0.0003
537 FEELING COLD 8 0.0003
538 SEPSIS 32 0.0003
539 WEIGHT FLUCTUATION 3 0.0003
540 DEMENTIA 8 0.0003
541 EOSINOPHILIA 5 0.0003
542 NEPHROLITHIASIS 13 0.0003
543 HAND FRACTURE 2 0.0003
544 FLATULENCE 16 0.0003
545 DIVERTICULUM 2 0.0003
546 METABOLIC ACIDOSIS 9 0.0003
547 JOINT INJURY 6 0.0003
548 FEAR OF INJECTION 2 0.0003
549 PNEUMONIA ASPIRATION 7 0.0003
550 GOUT 5 0.0003
551 PRODUCT SUBSTITUTION ISSUE 16 0.0003
552 UNEVALUABLE EVENT 21 0.0003
553 BACK INJURY 3 0.0003
554 PRODUCT DISPENSING ERROR 6 0.0003
555 PRODUCT PRESCRIBING ISSUE 6 0.0003
556 FLUID OVERLOAD 4 0.0003
557 NEEDLE ISSUE 8 0.0003
558 GASTROENTERITIS 4 0.0003
559 CARDIAC FAILURE 22 0.0003
560 INTENTIONAL UNDERDOSE 2 0.0003
561 EYE DISORDER 9 0.0003
562 SURGERY 16 0.0003
563 INFUSION RELATED REACTION 18 0.0003
564 DENTAL CARIES 3 0.0003
565 BLINDNESS TRANSIENT 2 0.0003
566 OEDEMA PERIPHERAL 33 0.0003
567 FOOT DEFORMITY 3 0.0003
568 SKIN DISORDER 9 0.0003
569 DRY SKIN 36 0.0003
570 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
571 HYPERTENSIVE CRISIS 3 0.0003
572 NECK PAIN 15 0.0003
573 BLOOD PRESSURE INCREASED 41 0.0003
574 HYPOGLYCAEMIA 13 0.0003
575 CARDIAC DISORDER 25 0.0003
576 PANCREATITIS ACUTE 6 0.0003
577 HEPATIC CIRRHOSIS 5 0.0003
578 BLOOD POTASSIUM DECREASED 8 0.0003
579 STATUS EPILEPTICUS 3 0.0003
580 BLOOD SODIUM DECREASED 5 0.0003
581 DYSPEPSIA 26 0.0003
582 CARDIO-RESPIRATORY ARREST 11 0.0003
583 DISCOMFORT 16 0.0003
584 BOWEL MOVEMENT IRREGULARITY 2 0.0003
585 SKIN DISCOLOURATION 12 0.0003
586 THROMBOSIS 21 0.0003
587 FEELING HOT 16 0.0003
588 INJECTION SITE RASH 8 0.0003
589 POST PROCEDURAL COMPLICATION 5 0.0003
590 HYPERTENSION 55 0.0003
591 ATRIOVENTRICULAR BLOCK 2 0.0003
592 CELLULITIS 13 0.0003
593 ABDOMINAL DISCOMFORT 43 0.0003
594 HEART RATE DECREASED 9 0.0003
595 SWOLLEN TONGUE 8 0.0003
596 SPINAL PAIN 3 0.0003
597 FATIGUE 199 0.0003
598 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 46 0.0003
599 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
600 DEHYDRATION 34 0.0003
601 CYANOSIS 4 0.0003
602 HEAD INJURY 8 0.0003
603 FURUNCLE 2 0.0003
604 GINGIVAL PAIN 2 0.0003
605 PYREXIA 86 0.0002
606 LOCALISED INFECTION 6 0.0002
607 VISION BLURRED 34 0.0002
608 NOCTURIA 3 0.0002
609 PANIC ATTACK 9 0.0002
610 MUSCLE TIGHTNESS 4 0.0002
611 BACK DISORDER 4 0.0002
612 BACK PAIN 57 0.0002
613 HYPERSOMNIA 7 0.0002
614 MULTIPLE FRACTURES 4 0.0002
615 INJECTION SITE MASS 9 0.0002
616 EYE SWELLING 9 0.0002
617 ILEUS 3 0.0002
618 HEADACHE 151 0.0002
619 AGEUSIA 6 0.0002
620 EOSINOPHIL COUNT INCREASED 2 0.0002
621 RASH PRURITIC 13 0.0002
622 INTESTINAL OBSTRUCTION 9 0.0002
623 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
624 BRAIN OEDEMA 3 0.0002
625 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
626 SWELLING 22 0.0002
627 INTRAOCULAR PRESSURE INCREASED 3 0.0002
628 ROTATOR CUFF SYNDROME 3 0.0002
629 ERYTHEMA 48 0.0002
630 LIVER FUNCTION TEST INCREASED 5 0.0002
631 INSOMNIA 62 0.0002
632 BLOOD MAGNESIUM DECREASED 2 0.0002
633 HIATUS HERNIA 3 0.0002
634 EXPOSURE VIA SKIN CONTACT 6 0.0002
635 DISEASE RECURRENCE 11 0.0002
636 CARDIAC MURMUR 2 0.0002
637 HYSTERECTOMY 2 0.0002
638 EYE PAIN 13 0.0002
639 SWELLING FACE 15 0.0002
640 PRODUCT DOSE OMISSION 15 0.0002
641 FEELING ABNORMAL 55 0.0002
642 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
643 JOINT STIFFNESS 6 0.0002
644 ASTHENIA 86 0.0002
645 DEVICE USE ISSUE 4 0.0002
646 BEDRIDDEN 3 0.0002
647 HYPERKALAEMIA 8 0.0002
648 TOOTH INFECTION 3 0.0002
649 SARS-COV-2 TEST POSITIVE 3 0.0002
650 URTICARIA 38 0.0002
651 LYMPHADENOPATHY 8 0.0002
652 HEAD DISCOMFORT 4 0.0002
653 DRUG ERUPTION 4 0.0002
654 DEPRESSION 51 0.0002
655 GALLBLADDER DISORDER 4 0.0002
656 MALIGNANT MELANOMA 3 0.0002
657 THIRST 4 0.0002
658 ORAL PAIN 5 0.0002
659 RASH PAPULAR 5 0.0002
660 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
661 ADVERSE DRUG REACTION 20 0.0002
662 DIZZINESS 111 0.0002
663 HEAVY MENSTRUAL BLEEDING 2 0.0002
664 PSORIATIC ARTHROPATHY 9 0.0002
665 HEART RATE IRREGULAR 5 0.0002
666 PRURITUS 85 0.0002
667 PALLOR 6 0.0002
668 PELVIC PAIN 4 0.0002
669 RESTLESS LEGS SYNDROME 4 0.0002
670 CYSTITIS 7 0.0002
671 TOXICITY TO VARIOUS AGENTS 37 0.0002
672 TREATMENT NONCOMPLIANCE 12 0.0002
673 OSTEOPOROSIS 9 0.0002
674 CORONARY ARTERY OCCLUSION 3 0.0002
675 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
676 INCREASED TENDENCY TO BRUISE 2 0.0002
677 CONDITION AGGRAVATED 66 0.0002
678 MUSCLE TWITCHING 5 0.0002
679 BLOOD GLUCOSE ABNORMAL 4 0.0002
680 PROCEDURAL PAIN 6 0.0002
681 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
682 HYPERSENSITIVITY 40 0.0002
683 DYSGEUSIA 16 0.0002
684 HUNGER 3 0.0002
685 THERAPY CESSATION 11 0.0002
686 CARPAL TUNNEL SYNDROME 3 0.0002
687 BLOOD TEST ABNORMAL 3 0.0002
688 DEVICE MALFUNCTION 15 0.0002
689 PAIN 131 0.0002
690 ARTERIOSCLEROSIS 2 0.0002
691 ARRHYTHMIA 10 0.0002
692 ECZEMA 11 0.0002
693 MUSCULOSKELETAL DISORDER 4 0.0002
694 RED BLOOD CELL COUNT DECREASED 6 0.0002
695 PARALYSIS 3 0.0002
696 CARDIOGENIC SHOCK 3 0.0002
697 DERMATITIS ATOPIC 11 0.0002
698 ACCIDENTAL UNDERDOSE 3 0.0002
699 WEIGHT DECREASED 58 0.0002
700 PANCREATIC CARCINOMA 6 0.0002
701 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
702 ARTHRALGIA 86 0.0002
703 DYSSTASIA 6 0.0002
704 WEIGHT INCREASED 46 0.0002
705 HEPATIC ENZYME INCREASED 14 0.0002
706 ABDOMINAL PAIN UPPER 42 0.0002
707 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
708 MEMORY IMPAIRMENT 28 0.0002
709 HEPATOMEGALY 2 0.0002
710 ARTHRITIS 16 0.0002
711 CARDIOMYOPATHY 3 0.0002
712 HOSPICE CARE 2 0.0002
713 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
714 DECREASED APPETITE 47 0.0002
715 OFF LABEL USE 177 0.0002
716 PULMONARY OEDEMA 9 0.0002
717 HAEMORRHAGE INTRACRANIAL 3 0.0002
718 DYSPHAGIA 19 0.0002
719 NEUROPATHY PERIPHERAL 19 0.0002
720 CORONARY ARTERY DISEASE 6 0.0002
721 ECONOMIC PROBLEM 3 0.0002
722 FEEDING DISORDER 4 0.0002
723 PRODUCT USE ISSUE 37 0.0002
724 FEBRILE NEUTROPENIA 13 0.0002
725 HYPOPHAGIA 5 0.0002
726 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
727 PHARYNGEAL OEDEMA 3 0.0002
728 DEVICE RELATED INFECTION 3 0.0002
729 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
730 INJECTION SITE WARMTH 4 0.0002
731 MYALGIA 33 0.0002
732 MUSCULOSKELETAL CHEST PAIN 3 0.0002
733 MALAISE 85 0.0002
734 ANKLE FRACTURE 3 0.0002
735 INFLAMMATION 10 0.0002
736 ANXIETY 55 0.0002
737 RENAL DISORDER 9 0.0002
738 EJECTION FRACTION DECREASED 3 0.0002
739 HAEMATOMA 5 0.0002
740 HYPERGLYCAEMIA 7 0.0002
741 DRUG DOSE OMISSION BY DEVICE 15 0.0002
742 PRODUCT QUALITY ISSUE 26 0.0002
743 LETHARGY 11 0.0002
744 DERMATITIS 4 0.0002
745 SPEECH DISORDER 10 0.0002
746 FOLLICULITIS 2 0.0002
747 SYNCOPE 19 0.0002
748 OCULAR HYPERAEMIA 9 0.0002
749 JOINT DISLOCATION 2 0.0002
750 DIARRHOEA 122 0.0002
751 INJECTION SITE REACTION 13 0.0002
752 RASH ERYTHEMATOUS 9 0.0002
753 SCIATICA 3 0.0002
754 RASH 82 0.0002
755 VOMITING 88 0.0002
756 HEREDITARY ANGIOEDEMA 2 0.0002
757 SKIN CANCER 4 0.0002
758 VISUAL IMPAIRMENT 23 0.0002
759 BURNING SENSATION 13 0.0002
760 FREQUENT BOWEL MOVEMENTS 5 0.0002
761 BLOOD POTASSIUM INCREASED 3 0.0002
762 FAECES DISCOLOURED 4 0.0002
763 MENTAL DISORDER 8 0.0002
764 CHOLELITHIASIS 6 0.0002
765 GAIT DISTURBANCE 35 0.0002
766 DRUG LEVEL INCREASED 3 0.0002
767 EXPIRED PRODUCT ADMINISTERED 6 0.0002
768 VERTIGO 11 0.0002
769 COAGULOPATHY 3 0.0002
770 GLOSSODYNIA 4 0.0002
771 ANAEMIA 34 0.0002
772 BLISTER 10 0.0002
773 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
774 NAUSEA 140 0.0002
775 PAIN IN JAW 5 0.0002
776 PERIPHERAL SWELLING 27 0.0002
777 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
778 ANGINA PECTORIS 5 0.0002
779 MUSCLE SPASMS 32 0.0002
780 TINNITUS 8 0.0002
781 NERVOUSNESS 9 0.0002
782 SYRINGE ISSUE 3 0.0002
783 NEUROTOXICITY 3 0.0002
784 LUNG NEOPLASM MALIGNANT 7 0.0002
785 ASCITES 5 0.0002
786 LYMPHOCYTE COUNT DECREASED 3 0.0002
787 BRADYCARDIA 9 0.0002
788 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
789 DRUG ABUSE 14 0.0002
790 PRODUCT PRESCRIBING ERROR 4 0.0002
791 POLLAKIURIA 7 0.0002
792 DRUG INEFFECTIVE 221 0.0002
793 ABDOMINAL PAIN 39 0.0002
794 SKIN BURNING SENSATION 12 0.0002
795 ACCIDENT 2 0.0002
796 ROAD TRAFFIC ACCIDENT 7 0.0002
797 OSTEOARTHRITIS 7 0.0002
798 RENAL FAILURE ACUTE 7 0.0002
799 RESTLESSNESS 6 0.0002
800 DYSURIA 6 0.0002
801 ENCEPHALOPATHY 4 0.0002
802 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
803 HAEMORRHAGE 17 0.0002
804 DEATH 140 0.0002
805 FEMUR FRACTURE 5 0.0002
806 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
807 THINKING ABNORMAL 3 0.0002
808 THROMBOCYTOPENIA 18 0.0002
809 SEPTIC SHOCK 7 0.0002
810 MIDDLE INSOMNIA 3 0.0002
811 PRODUCT STORAGE ERROR 14 0.0002
812 PHOTOPHOBIA 3 0.0002
813 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
814 ABDOMINAL PAIN LOWER 4 0.0002
815 PRODUCT COMPLAINT 4 0.0002
816 PULMONARY EMBOLISM 15 0.0002
817 PROTEINURIA 3 0.0002
818 INJECTION SITE SWELLING 12 0.0002
819 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
820 DEVICE ISSUE 14 0.0002
821 HAEMOGLOBIN DECREASED 16 0.0002
822 HIP FRACTURE 5 0.0002
823 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
824 UNRESPONSIVE TO STIMULI 4 0.0002
825 CONFUSIONAL STATE 25 0.0002
826 DIPLOPIA 4 0.0002
827 SOMNOLENCE 31 0.0002
828 PLASMA CELL MYELOMA 6 0.0002
829 SKIN FISSURES 3 0.0002
830 BLOOD CREATININE INCREASED 10 0.0002
831 DEAFNESS 4 0.0002
832 ANHEDONIA 4 0.0002
833 IMMUNE SYSTEM DISORDER 2 0.0002
834 URINARY RETENTION 5 0.0001
835 HAIR TEXTURE ABNORMAL 2 0.0001
836 PAIN IN EXTREMITY 44 0.0001
837 FULL BLOOD COUNT DECREASED 3 0.0001
838 INTENTIONAL PRODUCT MISUSE 13 0.0001
839 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
840 STOMATITIS 9 0.0001
841 DEVICE MECHANICAL ISSUE 2 0.0001
842 SKIN LESION 4 0.0001
843 RESPIRATORY ARREST 4 0.0001
844 ACNE 11 0.0001
845 MENTAL STATUS CHANGES 4 0.0001
846 ARTHROPATHY 8 0.0001
847 COORDINATION ABNORMAL 2 0.0001
848 WOUND 4 0.0001
849 RASH MACULAR 5 0.0001
850 HALLUCINATION, VISUAL 3 0.0001
851 HYPONATRAEMIA 8 0.0001
852 POOR QUALITY SLEEP 3 0.0001
853 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
854 INJECTION SITE BRUISING 11 0.0001
855 UNDERDOSE 10 0.0001
856 LABORATORY TEST ABNORMAL 4 0.0001
857 BLOOD PRESSURE DECREASED 9 0.0001
858 LIVER DISORDER 6 0.0001
859 DISEASE PROGRESSION 16 0.0001
860 URINARY INCONTINENCE 4 0.0001
861 DRUG INTOLERANCE 13 0.0001
862 COLON CANCER 2 0.0001
863 INJECTION SITE PAIN 41 0.0001
864 PARAESTHESIA 21 0.0001
865 DRUG DOSE OMISSION 22 0.0001
866 JOINT SWELLING 16 0.0001
867 PANCREATITIS 7 0.0001
868 DEVICE FAILURE 2 0.0001
869 HIP ARTHROPLASTY 2 0.0001
870 SHOCK 3 0.0001
871 DISTURBANCE IN ATTENTION 7 0.0001
872 OVERDOSE 28 0.0001
873 LIMB DISCOMFORT 4 0.0001
874 OEDEMA 7 0.0001
875 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
876 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
877 ALOPECIA 25 0.0001
878 NO ADVERSE EVENT 23 0.0001
879 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
880 ABNORMAL BEHAVIOUR 5 0.0001
881 BLOOD PRESSURE FLUCTUATION 3 0.0001
882 FIBROMYALGIA 3 0.0001
883 PRESYNCOPE 3 0.0001
884 DEEP VEIN THROMBOSIS 8 0.0001
885 BLINDNESS 5 0.0001
886 INJECTION SITE URTICARIA 3 0.0001
887 LIVER INJURY 3 0.0001
888 INFLUENZA LIKE ILLNESS 10 0.0001
889 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
890 SUICIDAL IDEATION 11 0.0001
891 BONE PAIN 7 0.0001
892 INJECTION SITE PRURITUS 8 0.0001
893 INCORRECT DOSE ADMINISTERED 27 0.0001
894 HEMIPARESIS 2 0.0001
895 FLUSHING 12 0.0001
896 DRUG RESISTANCE 3 0.0001
897 IRRITABILITY 7 0.0001
898 RECTAL HAEMORRHAGE 5 0.0001
899 THERAPEUTIC RESPONSE DECREASED 7 0.0001
900 DELIRIUM 4 0.0001
901 ILL-DEFINED DISORDER 7 0.0001
902 DEVICE USE ERROR 4 0.0001
903 AMENORRHOEA 2 0.0001
904 PLATELET COUNT DECREASED 12 0.0001
905 BREAST CANCER FEMALE 3 0.0001
906 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
907 FEAR 3 0.0001
908 C-REACTIVE PROTEIN INCREASED 4 0.0001
909 ACCIDENTAL OVERDOSE 4 0.0001
910 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
911 HAEMATOCHEZIA 6 0.0001
912 ADVERSE EVENT 10 0.0001
913 BLOOD CHOLESTEROL INCREASED 5 0.0001
914 RENAL IMPAIRMENT 9 0.0001
915 HYPOAESTHESIA 16 0.0001
916 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
917 CEREBROVASCULAR ACCIDENT 18 0.0001
918 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
919 FRACTURE 2 0.0001
920 BLOOD URINE PRESENT 2 0.0001
921 GASTRIC ULCER 2 0.0001
922 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
923 BLOOD GLUCOSE DECREASED 5 0.0001
924 GLAUCOMA 2 0.0001
925 HERNIA 2 0.0001
926 ERUCTATION 2 0.0001
927 INTERSTITIAL LUNG DISEASE 5 0.0001
928 CYTOKINE RELEASE SYNDROME 2 0.0001
929 APHASIA 3 0.0001
930 DEVICE BREAKAGE 4 0.0001
931 BODY TEMPERATURE INCREASED 2 0.0001
932 DRUG ADMINISTRATION ERROR 3 0.0001
933 INTENTIONAL DRUG MISUSE 2 0.0001
934 BLOOD GLUCOSE INCREASED 18 0.0001
935 AGITATION 7 0.0001
936 MOVEMENT DISORDER 3 0.0001
937 HYPERHIDROSIS 12 0.0001
938 HALLUCINATION 7 0.0001
939 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
940 DIABETES MELLITUS 7 0.0001
941 APPLICATION SITE PAIN 2 0.0001
942 COLITIS ULCERATIVE 4 0.0001
943 ANGER 3 0.0001
944 INJECTION SITE ERYTHEMA 11 0.0001
945 RHEUMATOID ARTHRITIS 10 0.0001
946 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
947 SKIN IRRITATION 4 0.0001
948 NIGHTMARE 3 0.0001
949 MYOCARDIAL INFARCTION 15 0.0001
950 PSORIASIS 11 0.0001
951 PRODUCT ADHESION ISSUE 3 0.0001
952 DRUG EFFECT INCOMPLETE 3 0.0001
953 CRYING 3 0.0001
954 AGGRESSION 4 0.0001
955 MUSCULOSKELETAL STIFFNESS 7 0.0001
956 HOT FLUSH 6 0.0001
957 LOSS OF CONSCIOUSNESS 10 0.0001
958 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
959 GASTRITIS 2 0.0001
960 DISORIENTATION 3 0.0001
961 NEOPLASM MALIGNANT 5 0.0001
962 EXTRA DOSE ADMINISTERED 3 0.0001
963 BLOOD BILIRUBIN INCREASED 2 0.0001
964 NEUTROPENIA 10 0.0001
965 PANCYTOPENIA 4 0.0001
966 SKIN EXFOLIATION 6 0.0001
967 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
968 HYPOACUSIS 3 0.0001
969 DEVICE LEAKAGE 3 0.0001
970 BLADDER CANCER 4 0.0001
971 HEPATIC FAILURE 2 0.0001
972 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
973 EPILEPSY 2 0.0001
974 EMOTIONAL DISORDER 2 0.0001
975 BONE DENSITY DECREASED 2 0.0001
976 COMA 3 0.0001
977 LACTIC ACIDOSIS 2 0.0001
978 IMPAIRED HEALING 2 0.0001
979 LEUKOPENIA 3 0.0001
980 GASTRIC DISORDER 2 0.0001
981 EMOTIONAL DISTRESS 7 0.0001
982 DEPRESSED MOOD 3 0.0001
983 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
984 ABORTION SPONTANEOUS 2 0.0000
985 DYSKINESIA 2 0.0000
986 EXPOSURE DURING PREGNANCY 3 0.0000
987 ANGIOEDEMA 2 0.0000
988 INJURY 3 0.0000
989 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
990 DRUG EFFECT DECREASED 2 0.0000
991 CONVULSION 2 0.0000
992 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
993 BREAST CANCER 3 0.0000
994 INJECTION SITE HAEMORRHAGE 2 0.0000